SEARCH

SEARCH BY CITATION

References

  • 1
    Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149: 443454.
  • 2
    Klaassen T, Verhey FRJ, Sneijders GHJM, et al. Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 1995; 7: 281286.
  • 3
    Caley CF, Friedman JH. Does fluoxetine exacerbate Parkinson's disease? J Clin Psychiatry 1992; 53: 278282.
  • 4
    Ceravolo R, Nuti A, Piccinni A, et al. Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology 2000; 55: 12161218.
  • 5
    Tesei S, Antonini A, Canesi M, et al. Tolerability of paroxetine in Parkinson's disease: a prospective study. Mov Disord 2000; 15: 986989.
  • 6
    Jansen Steur ENH. Increase of Parkinson disability after fluoxetine medication. Neurology 1993; 43: 211213.
  • 7
    Richard IH, Maughn A, Kurlan R. Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series. Mov Disorder 1999; 14: 155157.
  • 8
    Simons JA. Fluoxetine in Parkinson's disease. Mov Disorder 1996; 11: 581582.
  • 9
    Herings RM, Bakker A, Stricker BH, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 1992; 46: 136140.
  • 10
    Van De Vijver DAMC, Stricker BHC, Breteler MMB, et al. Evaluation of antiparkinsonian drugs as a marker for Parkinson's disease in pharmacy records. Pharm World Sci 2001; 23: 148152.
  • 11
    Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology. Neurology 1998; 50: S1S57.
  • 12
    Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181184.
  • 13
    Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 492496.
  • 14
    De Waal MW, Stolk J, Van Marwijk HW, Springer MP. Prescription of antidepressants in family practice. Ned Tijdschr Geneeskd 1996; 140: 21312134.
  • 15
    Isacsson G, Redfors I, Wasserman D, Bergman U. Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden. Br Med J 1994; 309: 15461549.
  • 16
    Baldessarini RJ, Marsh ER, Kula NS. Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain Res 1992; 579: 152156.
  • 17
    Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996; 57: 449454.